Genmab inks bispecific antibody deal with Janssen
06:10 EDT 16 Jul 2012 | SCRIP
As it bids to establish its Duobody technology platform as a gold standard for creating bispecific antibodies, Danish biotech Genmab has entered into a collaboration with the Johnson & Johnson company Janssen Biotech. As part of the.....
Original Article: Genmab inks bispecific antibody deal with Janssen
More From BioPortfolio on "Genmab inks bispecific antibody deal with Janssen"
Biotech & Healthcare Channels
World News
Life Science Events
Corporate Database
Market Reports
Categories
Search BioPortfolio:
